Showing results (131-140 of 263) with videos related to

Sort By:
Pageof 27
Haematologica|March 7, 2007
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 studyXavier Thomas, Stefan Suciu, Bernard Rio, et al.
Blood|July 5, 2007
Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLsJulie Bergeron, Emmanuelle Clappier, Isabelle Radford, et al.
Blood|March 14, 2007
A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemiaJean-Luc Harousseau, Jeffrey E Lancet, Josy Reiffers, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized studyXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.
Blood|September 28, 2002
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Claude Preudhomme, Christophe Sagot, Nicolas Boissel, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 8, 2016
Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution ExperienceMaël Heiblig, Mohamed Elhamri, Isabelle Tigaud, et al.
Haematologica|October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaJean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
Molecular Microbiology|August 2, 2003
Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coliDelphine Destoumieux-Garzón, Xavier Thomas, Mónica Santamaria, et al.
Plos One|January 20, 2017
Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML PatientsVirginie Marcel, Frédéric Catez, Caroline M Berger, et al.
Leukemia & Lymphoma|May 18, 2016
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experienceMaël Heiblig, Caroline Le Jeune, Mohamed Elhamri, et al.
Pageof 27